Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

J.A.J. Verdonschot, J.P. Ferreira, P. Pellicori, H.P. Brunner-La Rocca, A.L. Clark, F. Cosmi, J. Cuthbert, N. Girerd, B. Mariottoni, J. Petutschnigg, P. Rossignol, J.G.F. Cleland, F. Zannad, S.R.B. Heymans*, HOMAGE “Heart Omics in AGEing” consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number163
Number of pages10
JournalCardiovascular Diabetology
Volume20
Issue number1
DOIs
Publication statusPublished - 9 Aug 2021

Keywords

  • Diabetes
  • Biomarker
  • Heart failure
  • Spironolactone
  • Fibrosis
  • GROWTH-DIFFERENTIATION FACTOR-15
  • SPIRONOLACTONE
  • INFLAMMATION

Cite this